Back to results
US 2007/0191266 A1Published application
Methods of treating blepharospasm using cyclosporine components
AssigneeAllergan, Inc.
InventorMITCHELL F. BRIN
Life of this patent
Estimating the term…
Abstract
Methods of treating humans or animals afflicted with primary blepharospasm, for example, benign essential blepharospasm, or secondary blepharospasm not caused by an ocular surface disease or condition, are component to a human or animal so afflicted.
Claims21
A method of treating blepharospasm, the method comprising:
- administering a therapeutically effective amount of a cyclosporine component to a human or animal afflicted with blepharospasm not resulting from local oculosurface disease, the administering step being effective in treating the blepharospasm.
A method of treating blepharospasm, the method comprising:
- administering a therapeutically effective amount of a cyclosporine component to a human or animal afflicted with blepharospasm not caused by keratoconjunctivitis sicca, the administering step being effective in treating the blepharospasm.
Dependencies are inferred from the claim text.